☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
Delaware |
94-3125814 | |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Common Stock ($0.001 par value) |
IVAC |
The Nasdaq Stock Market LLC (Nasdaq Global Select) |
Large accelerated filer | ☐ | Accelerated filer | ☒ | |||
Non-accelerated filer |
☐ |
Smaller reporting company | ☒ | |||
Emerging growth company | ☐ |
Item 1. |
Business |
TFE Products |
Applications and Features | |
HDD Equipment Market | ||
200 Lean ® Disk Sputtering System |
• Uses PVD and chemical vapor deposition (“CVD”) technologies. • Deposits magnetic films, non-magnetic films and protective carbon-based overcoats.• Provides high-throughput for small-substrate processing. • Over 164 units installed. | |
Upgrades, spares, consumables and services (non-systems business) |
• Upgrades to the installed base to support the continued growth in areal density or reduce the manufacturing cost per disk. | |
DCP Market | ||
INTEVAC VERTEX ® System |
• Utilizes vertical sputtering for multiple film types. • Provides high-throughput for small-substrate processing. • Uses patented carbon deposition source. • Modular design enables expandability. • Enables low-temperature processing. | |
INTEVAC VERTEX ® Spectra System |
• Extension of the VERTEX system. • Incorporates multiple source technologies in a single system. • Uses proprietary ion beam processing for deposition and etching. • Enables unique patterned NCVM and hard AR coatings. | |
INTEVAC VERTEX ® Marathon System |
• Versatile platform for high volume manufacturing of multi-step, multi-layer optical coatings. • Enables diverse coatings - DiamondClad, patterned NCVM and AR films. | |
Solar PV Market | ||
INTEVAC MATRIX PVD System |
• Deposits electrical contacts and conductor layers, reflective layers, and transparent conductive oxide layers, all of which are critical to the efficiency of solar cells. • Includes patented Linear Scanning Magnetic Array (“LSMA”) magnetron source, with industry-leading target utilization rate of over 65 percent. • Provides high-throughput for small-substrate processing. | |
INTEVAC MATRIX Implant System |
• Utilizes the chambers and transport mechanism of the MATRIX platform while using the implant sources from the ENERG i | |
ENERG i ® Implant System |
• Supports both phosphorus and boron dopant technologies. • Extendable to new advanced solar cell structures. |
TFE Products |
Applications and Features | |
ASP Market | ||
INTEVAC MATRIX PVD System |
• Deposits barrier/seed layers for fan-out RDL.• Includes LSMA magnetron source, with industry-leading target utilization rate of over 65 percent. • Provides high-throughput and low cost of ownership for small-substrate or large panel processing. • Provides flexibility for handling round, square, or rectangular substrates for fan-out packaging. | |
Adjacent Markets | ||
INTEVAC MATRIX System |
• Incorporates multiple thin-film deposition techniques such as PVD, CVD, Etch, Implant, heating and cooling. • Consists of high-speed linear transport. • Flexible design enables handling of various different small substrate sizes and shapes. • Performs double-sided coating within vacuum. |
2021 |
2020 |
|||||||
Seagate Technology |
60 | % | 79 | % | ||||
Western Digital Corporation |
25 | % | 18 | % | ||||
Amkor Technology, Inc. |
10 | % | * |
Name |
Age |
Position | ||||
Executive Officers: |
||||||
Nigel D. Hunton |
61 | President and Chief Executive Officer | ||||
James Moniz |
64 | Executive Vice President, Finance and Administration, Chief Financial Officer, Secretary and Treasurer | ||||
Jay Cho |
57 | Executive Vice President and General Manager, TFE | ||||
Other Key Officers: |
||||||
Terry Bluck |
62 | Chief Technology Officer, TFE | ||||
Kimberly Burk |
56 | Senior Vice President, Global Human Resources |
Item 1A. |
Risk Factors |
Item 1B. |
Unresolved Staff Comments |
Item 2. |
Properties |
Location |
Square Footage |
Principal Use | ||||
Santa Clara, California |
169,583 | * | Corporate Headquarters; Marketing, Manufacturing, Engineering and Customer Support | |||
Singapore |
31,947 | Manufacturing and Customer Support | ||||
Malaysia |
1,291 | Customer Support | ||||
Shenzhen, China |
2,568 | Customer Support |
* | In connection with the disposition of our Photonics business, we entered into a lease assignment agreement with EOTECH that assigns the lease obligation for two buildings in our California campus consisting of 94,890 square feet of rentable space to EOTECH. As part of the assignment, we agreed to subsidize a portion of EOTECH’s lease payments through the remainder of the lease term which expires in March 2024. |
Item 3. |
Legal Proceedings |
Item 4. |
Mine Safety Disclosures |
Item 5. |
Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities |
Item 6. |
Item 7. |
Management’s Discussion and Analysis of Financial Condition and Results of Operations |
• | Overview: |
• | Results of Operations: |
• | Liquidity and Capital Resources: |
• | Critical Accounting Policies and Estimates: |
Fiscal Year |
2021 |
2020 |
Change 2021 vs. 2020 |
|||||||||
(in thousands, except percentages and per share amounts) |
||||||||||||
Net revenues |
$ | 38,524 | $ | 52,128 | $ | (13,604 | ) | |||||
Gross profit |
$ | 7,067 | $ | 22,417 | $ | (15,350 | ) | |||||
Gross margin percent |
18.3 | % | 43.0 | % | (24.7) points | |||||||
Operating loss |
$ | (22,476 | ) | $ | (8,880 | ) | $ | (13,596 | ) | |||
Net loss from continuing operations |
$ | (23,057 | ) | $ | (10,435 | ) | $ | (12,622 | ) | |||
Net income from discontinued operations, net of tax |
$ | 49,677 | $ | 11,491 | $ | 38,186 | ||||||
Net income |
$ | 26,620 | $ | 1,056 | $ | 25,564 | ||||||
Net income per basic and diluted share |
$ | 1.09 | $ | 0.04 | $ | 1.05 |
2021 |
2020 |
Change 2021 vs. 2020 |
||||||||||
(in thousands) |
||||||||||||
Total net revenues |
$ | 38,524 | $ | 52,128 | $ | (13,604 | ) | |||||
|
|
|
|
|
|
January 1, 2022 |
January 2, 2021 |
|||||||
(in thousands) |
||||||||
Total backlog |
$ | 24,725 | $ | 5,623 | ||||
|
|
|
|
2021 |
2020 |
|||||||
Seagate Technology |
60 | % | 79 | % | ||||
Western Digital Corporation |
25 | % | 18 | % | ||||
Amkor Technology, Inc. |
10 | % | * |
2021 |
2020 |
|||||||
(in thousands) |
||||||||
United States |
$ | 3,670 | $ | 6,450 | ||||
Asia |
31,004 | 45,611 | ||||||
Europe |
3,850 | 67 | ||||||
|
|
|
|
|||||
Total net revenues |
$ | 38,524 | $ | 52,128 | ||||
|
|
|
|
Fiscal Year |
Change 2021 vs. 2020 |
|||||||||||
2021 |
2020 |
|||||||||||
(in thousands, except percentages) |
||||||||||||
Total gross profit |
$ | 7,067 | $ | 22,417 | $ | (15,350 | ) | |||||
% of net revenues |
18.3 | % | 43.0 | % |
Fiscal Year |
Change 2021 vs. 2020 |
|||||||||||
2021 |
2020 |
|||||||||||
(in thousands) |
||||||||||||
Research and development expense |
$ | 12,176 | $ | 13,205 | $ | (1,029 | ) |
Fiscal Year |
Change 2021 vs. 2020 |
|||||||||||
2021 |
2020 |
|||||||||||
(in thousands) |
||||||||||||
Selling, general and administrative expense |
$ | 17,367 | $ | 18,092 | $ | (725 | ) |
Fiscal Year |
Change 2021 vs. 2020 |
|||||||||||
2021 |
2020 |
|||||||||||
(in thousands) |
||||||||||||
Interest income and other income (expense), net |
$ | (6 | ) | $ | 156 | $ | (162 | ) |
Fiscal Year |
Change 2021 vs. 2020 |
|||||||||||
2021 |
2020 |
|||||||||||
(in thousands) |
||||||||||||
Provision for income taxes |
$ | 575 | $ | 1,711 | $ | (1,136 | ) |
Fiscal Year |
Change 2021 vs. 2020 |
|||||||||||
2021 |
2020 |
|||||||||||
(in thousands) |
||||||||||||
Income from discontinued operations, net of tax |
$ | 49,677 | $ | 11,491 | $ | 38,186 |
January 1, 2022 |
January 2, 2021 |
|||||||
(in thousands) |
||||||||
Cash and cash equivalents |
$ | 102,728 | $ | 29,341 | ||||
Restricted cash |
786 | 787 | ||||||
Short-term investments |
10,221 | 14,839 | ||||||
Long-term investments |
7,427 | 5,388 | ||||||
|
|
|
|
|||||
Total cash, cash-equivalents, restricted cash and investments |
$ | 121,162 | $ | 50,355 | ||||
|
|
|
|
Item 7A. |
Quantitative and Qualitative Disclosures About Market Risk |
Item 8. |
Financial Statements and Supplementary Data |
Page |
||||
30 | ||||
32 | ||||
33 | ||||
34 | ||||
35 | ||||
36 | ||||
37 |
/s/ BPM LLP |
We have served as the Company’s auditor since 2015. |
San Jose, California |
February 17, 2022 |
January 1, 2022 |
January 2, 2021 |
|||||||
(In thousands, except par value) |
||||||||
ASSETS |
||||||||
Current assets: |
||||||||
Cash and cash equivalents |
$ | 102,728 | $ | 29,341 | ||||
Short-term investments |
10,221 | 14,839 | ||||||
Trade and other accounts receivable, net of allowances of $0 at both January 1, 2022 and January 2, 2021 |
14,261 | 28,646 | ||||||
Inventories |
5,791 | 21,689 | ||||||
Prepaid expenses and other current assets |
1,827 | 1,893 | ||||||
|
|
|
|
|||||
Total current assets |
134,828 | 96,408 | ||||||
Property, plant and equipment, net |
4,759 | 11,004 | ||||||
Operating lease right-of-use |
4,520 | 8,165 | ||||||
Long-term investments |
7,427 | 5,388 | ||||||
Restricted cash |
786 | 787 | ||||||
Deferred income taxes and other long-term assets |
5,449 | 5,486 | ||||||
|
|
|
|
|||||
Total assets |
$ | 157,769 | $ | 127,238 | ||||
|
|
|
|
|||||
LIABILITIES AND STOCKHOLDERS’ EQUITY |
||||||||
Current liabilities: |
||||||||
Current operating lease liabilities |
$ | 3,119 | $ | 2,853 | ||||
Accounts payable |
5,320 | 4,259 | ||||||
Accrued payroll and related liabilities |
5,505 | 7,679 | ||||||
Other accrued liabilities |
3,665 | 3,598 | ||||||
Customer advances |
2,107 | 33 | ||||||
|
|
|
|
|||||
Total current liabilities |
19,716 | 18,422 | ||||||
Noncurrent liabilities: |
||||||||
Noncurrent operating lease liabilities |
3,675 | 6,803 | ||||||
Other long-term liabilities |
363 | 457 | ||||||
|
|
|
|
|||||
Total noncurrent liabilities |
4,038 | 7,260 | ||||||
Commitments and contingencies |
||||||||
Stockholders’ equity: |
||||||||
Undesignated preferred stock, $0.001 par value, 10,000 shares authorized, no |
— | — | ||||||
Common stock, $0.001 par value: |
||||||||
Authorized shares — 50,000 issued and outstanding shares — 24,636 and 23,874 at January 1, 2022 and January 2, 2021, respectively |
25 | 24 | ||||||
Additional paid-in capital |
199,073 | 193,173 | ||||||
Treasury stock, 5,087 shares at both January 1, 2022 and January 2, 2021 |
(29,551 | ) | (29,551 | ) | ||||
Accumulated other comprehensive income |
578 | 640 | ||||||
Accumulated deficit |
(36,110 | ) | (62,730 | ) | ||||
|
|
|
|
|||||
Total stockholders’ equity |
134,015 | 101,556 | ||||||
|
|
|
|
|||||
Total liabilities and stockholders’ equity |
$ | 157,769 | $ | 127,238 | ||||
|
|
|
|
Year Ended, |
||||||||
January 1, 2022 |
January 2, 2021 |
|||||||
(In thousands, except per share amounts) |
||||||||
Net revenues |
$ | 38,524 | $ | 52,128 | ||||
Cost of net revenues |
31,457 | 29,711 | ||||||
|
|
|
|
|||||
Gross profit |
7,067 | 22,417 | ||||||
Operating expenses: |
||||||||
Research and development |
12,176 | 13,205 | ||||||
Selling, general and administrative |
17,367 | 18,092 | ||||||
|
|
|
|
|||||
Total operating expenses |
29,543 | 31,297 | ||||||
|
|
|
|
|||||
Operating loss |
(22,476 | ) | (8,880 | ) | ||||
|
|
|
|
|||||
Interest income |
29 | 284 | ||||||
Other income (expense), net |
(35 | ) | (128 | ) | ||||
|
|
|
|
|||||
Loss from continuing operations before provision for income taxes |
(22,482 | ) | (8,724 | ) | ||||
Provision for income taxes |
575 | 1,711 | ||||||
|
|
|
|
|||||
Net loss from continuing operations |
(23,057 | ) | (10,435 | ) | ||||
|
|
|
|
|||||
Income from discontinued operations: |
||||||||
Income (loss) from Photonics division, net of tax |
(4,664 | ) | 11,491 | |||||
Gain on sale of Photonics division, net of tax |
54,341 | — | ||||||
|
|
|
|
|||||
Total income from discontinued operations, net of tax |
49,677 | 11,491 | ||||||
|
|
|
|
|||||
Net income |
$ | 26,620 | $ | 1,056 | ||||
|
|
|
|
|||||
Net income (loss) per share: |
||||||||
Basic and diluted—continuing operations |
$ | (0.95 | ) | $ | (0.44 | ) | ||
Basic and diluted—discontinued operations |
$ | 2.04 | $ | 0.49 | ||||
Basic and diluted—net income |
$ | 1.09 | $ | 0.04 | ||||
Weighted average shares outstanding: |
||||||||
Basic and diluted |
24,348 | 23,669 |
Year Ended, |
||||||||
January 1, 2022 |
January 2, 2021 |
|||||||
(In thousands) |
||||||||
Net income |
$ | 26,620 | $ | 1,056 | ||||
Other comprehensive income (loss), before tax |
||||||||
Change in unrealized net gain on available-for-sale |
(68 | ) | (5 | ) | ||||
Foreign currency translation gains |
6 | 221 | ||||||
|
|
|
|
|||||
Other comprehensive income (loss), before tax |
(62 | ) | 216 | |||||
Income tax expense related to items in other comprehensive income (loss) |
— | — | ||||||
|
|
|
|
|||||
Other comprehensive income (loss), net of tax |
(62 | ) | 216 | |||||
|
|
|
|
|||||
Comprehensive income |
$ | 26,558 | $ | 1,272 | ||||
|
|
|
|
Common Stock |
Additional Paid-In Capital |
Treasury Stock |
Accumulated Other Comprehensive Income |
Accumulated Deficit |
Total Stockholders’ Equity |
|||||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||||||
Balance at December 28, 2019 |
23,346 | $ | 23 | $ | 188,290 | 4,989 | $ | (29,158 | ) | $ | 424 | $ | (63,786 | ) | $ | 95,793 | ||||||||||||||||
Shares issued in connection with: |
||||||||||||||||||||||||||||||||
Exercise of stock options |
67 | — | 326 | — | — | — | — | 326 | ||||||||||||||||||||||||
Settlement of RSUs |
244 | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Employee stock purchase plan |
392 | 1 | 1,570 | — | — | — | — | 1,571 | ||||||||||||||||||||||||
Shares withheld in connection with net share settlement of RSUs |
(77 | ) | — | (402 | ) | — | — | — | — | (402 | ) | |||||||||||||||||||||
Equity-based compensation expense |
— | — | 3,389 | — | — | — | — | 3,389 | ||||||||||||||||||||||||
Net income |
— | — | — | — | — | — | 1,056 | 1,056 | ||||||||||||||||||||||||
Other comprehensive income |
— | — | — | — | — | 216 | — | 216 | ||||||||||||||||||||||||
Common stock repurchases |
(98 | ) | — | — | 98 | (393 | ) | — | — | (393 | ) | |||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at January 2, 2021 |
23,874 | $ | 24 | $ | 193,173 | 5,087 | $ | (29,551 | ) | $ | 640 | $ | (62,730 | ) | $ | 101,556 | ||||||||||||||||
Shares issued in connection with: |
||||||||||||||||||||||||||||||||
Exercise of stock options |
76 | — | 440 | — | — | — | — | 440 | ||||||||||||||||||||||||
Settlement of RSUs |
383 | — | — | — | — | — | — | — | ||||||||||||||||||||||||
Employee stock purchase plan |
435 | 1 | 2,191 | — | — | — | — | 2,192 | ||||||||||||||||||||||||
Shares withheld in connection with net share settlement of RSUs |
(132 | ) | — | (734 | ) | — | — | — | — | (734 | ) | |||||||||||||||||||||
Equity-based compensation expense |
— | — | 4,003 | — | — | — | — | 4,003 | ||||||||||||||||||||||||
Net income |
— | — | — | — | — | — | 26,620 | 26,620 | ||||||||||||||||||||||||
Other comprehensive loss |
— | — | — | — | — | (62 | ) | — | (62 | ) | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||
Balance at January 1 2022 |
24,636 | $ | 25 | $ | 199,073 | 5,087 | $ | (29,551 | ) | $ | 578 | $ | (36,110 | ) | $ | 134,015 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended |
||||||||
January 1 2022 |
January 2, 2021 |
|||||||
(In thousands) |
||||||||
Operating activities |
||||||||
Net income |
$ | 26,620 | $ | 1,056 | ||||
Adjustments to reconcile net income to net cash and cash equivalents provided by operating activities: |
||||||||
Depreciation and amortization |
3,456 | 3,206 | ||||||
Net amortization (accretion) of investment premiums and discounts |
109 | 12 | ||||||
Amortization of intangible assets |
— | 274 | ||||||
Gain on sale of Photonics division |
(54,341 | ) | — | |||||
Asset impairment charges |
1,246 | — | ||||||
Equity-based compensation |
4,003 | 3,389 | ||||||
Straight-line rent adjustment and amortization of lease incentives |
(463 | ) | (286 | ) | ||||
Deferred income taxes |
25 | 917 | ||||||
Changes in assets and liabilities: |
||||||||
Accounts receivable |
10,850 | (27 | ) | |||||
Inventories |
9,597 | 3,218 | ||||||
Prepaid expenses and other assets |
6 | (462 | ) | |||||
Accounts payable |
(932 | ) | 60 | |||||
Accrued payroll and other accrued liabilities |
(1,972 | ) | 1,467 | |||||
Customer advances |
2,074 | (3,974 | ) | |||||
|
|
|
|
|||||
Total adjustments |
(26,342 | ) | 7,794 | |||||
|
|
|
|
|||||
Net cash and cash equivalents provided by operating activities |
278 | 8,850 | ||||||
Investing activities |
||||||||
Purchase of investments |
(17,148 | ) | (23,342 | ) | ||||
Proceeds from sales and maturities of investments |
19,550 | 25,355 | ||||||
Proceeds from sale of Photonics division |
70,000 | — | ||||||
Purchase of leasehold improvements and equipment |
(1,198 | ) | (2,612 | ) | ||||
|
|
|
|
|||||
Net cash and cash equivalents provided by (used in) investing activities |
71,204 | (599 | ) | |||||
Financing activities |
||||||||
Proceeds from issuance of common stock |
2,632 | 1,897 | ||||||
Common stock repurchases |
— | (393 | ) | |||||
Taxes paid related to net share settlement |
(734 | ) | (402 | ) | ||||
|
|
|
|
|||||
Net cash and cash equivalents provided by financing activities |
1,898 | 1,102 | ||||||
Effect of exchange rate changes on cash |
6 | 221 | ||||||
|
|
|
|
|||||
Net increase in cash, cash equivalents and restricted cash |
73,386 | 9,574 | ||||||
Cash, cash equivalents and restricted cash at beginning of period |
30,128 | 20,554 | ||||||
|
|
|
|
|||||
Cash, cash equivalents and restricted cash at end of period |
$ | 103,514 | $ | 30,128 | ||||
|
|
|
|
|||||
Cash paid (received) for: |
||||||||
Income taxes |
$ | 559 | $ | 850 | ||||
Income tax refund |
$ | (18 | ) | $ | (157 | ) |
Foreign currency |
Unrealized holding gains (losses) on available-for-sale investments |
Total |
||||||||||
(in thousands) |
||||||||||||
Balance at December 28, 2019 |
$ | 381 | $ | 43 | $ | 424 | ||||||
|
|
|
|
|
|
|||||||
Other comprehensive income (loss) before reclassification |
221 | (5 | ) | 216 | ||||||||
Amounts reclassified from other comprehensive income (loss) |
— | — | — | |||||||||
|
|
|
|
|
|
|||||||
Net current-period other comprehensive income (loss) |
221 | (5 | ) | 216 | ||||||||
|
|
|
|
|
|
|||||||
Balance at January 2, 2021 |
602 | 38 | 640 | |||||||||
|
|
|
|
|
|
|||||||
Other comprehensive income (loss) before reclassification |
6 | (68 | ) | (62 | ) | |||||||
Amounts reclassified from other comprehensive income (loss) |
— | — | — | |||||||||
|
|
|
|
|
|
|||||||
Net current-period other comprehensive income (loss) |
6 | (68 | ) | (62 | ) | |||||||
|
|
|
|
|
|
|||||||
Balance at January 1, 2022 |
$ | 608 | $ | (30 | ) | $ | 578 | |||||
|
|
|
|
|
|
Cash proceeds |
$ | 70,000 | ||
Working capital adjustment |
(74 | ) | ||
|
|
|||
69,926 | ||||
Assets sold: |
||||
Accounts receivable |
3,535 | |||
Inventories |
6,301 | |||
Other current assets |
72 | |||
Property, plant and equipment |
3,987 | |||
|
|
|||
Total assets sold |
13,895 | |||
Liabilities divested: |
||||
Accounts payable |
888 | |||
Other accrued expenses |
594 | |||
|
|
|||
Total liabilities divested |
1,482 | |||
Transaction and other costs |
(3,172 | ) | ||
|
|
|||
Gain on sale |
$ | 54,341 | ||
|
|
Year Ended, |
||||||||
January 1, 2022 |
January 2, 2021 |
|||||||
(In thousands, except per share amounts) |
||||||||
Net revenues: |
||||||||
Systems and components |
$ | 15,932 | $ | 22,751 | ||||
Technology development |
11,735 | 22,945 | ||||||
|
|
|
|
|||||
Total net revenues |
27,667 | 45,696 | ||||||
Cost of net revenues: |
||||||||
Systems and components |
12,252 | 12,520 | ||||||
Technology development |
8,885 | 15,048 | ||||||
|
|
|
|
|||||
Total cost of net revenues |
21,137 | 27,568 | ||||||
Gross profit |
6,530 | 18,128 |
Year Ended, |
||||||||
January 1, 2022 |
January 2, 2021 |
|||||||
(In thousands, except per share amounts) |
||||||||
Operating expenses: |
||||||||
Research and development |
2,653 | 888 | ||||||
Selling, general and administrative |
5,937 | 5,805 | ||||||
Asset impairment and restructuring charges |
2,604 | — | ||||||
|
|
|
|
|||||
Total operating expenses |
11,194 | 6,693 | ||||||
|
|
|
|
|||||
Operating income (loss)—discontinued operations |
(4,664 | ) | 11,435 | |||||
Other income (expense)—discontinued operations |
— | 56 | ||||||
|
|
|
|
|||||
Income (loss) discontinued operations before provision for (benefit from) income taxes |
(4,664 | ) | 11,491 | |||||
Gain on disposal of discontinued operations before income taxes |
54,341 | — | ||||||
|
|
|
|
|||||
Total income from discontinued operations, before tax |
49,677 | 11,491 | ||||||
Provision for (benefit from) income taxes |
— | — | ||||||
|
|
|
|
|||||
Net income from discontinued operations net of tax |
$ | 49,677 | $ | 11,491 | ||||
|
|
|
|
2021 |
2020 |
|||||||
(in thousands) |
||||||||
Depreciation and amortization |
$ | 1,366 | $ | 1,123 | ||||
Amortization of intangible assets |
$ | — | $ | 36 | ||||
Asset impairment charges |
$ | 1,246 | $ | — | ||||
Equity-based compensation |
$ | 1,167 | $ | 959 | ||||
Purchase of leasehold improvements and equipment |
$ | 429 | $ | 636 |
2021 |
2020 |
|||||||||||||||||||||||||||||||
(in thousands) |
||||||||||||||||||||||||||||||||
HDD |
DCP |
PV |
ASP |
Total |
HDD |
PV |
Total |
|||||||||||||||||||||||||
Systems, upgrades and spare parts | $ 28,300 |
$ 3 |
$ 258 |
$ 3,850 |
$ 32,411 |
$ 45,620 |
$ 426 |
$ 46,046 |
||||||||||||||||||||||||
Field service | 6,031 | 14 | 68 | — | 6,113 | 6,080 | 2 | 6,082 | ||||||||||||||||||||||||
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||
Total TFE net revenues |
$ | 34,331 | $ | 17 | $ | 326 | $ | 3,850 | $ | 38,524 | $ | 51,700 | $ | 428 | $ | 52,128 | ||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2021 |
2020 |
|||||||
(in thousands) |
||||||||
United States |
$ | 3,670 | $ | 6,450 | ||||
Asia |
31,004 | 45,611 | ||||||
Europe |
3,850 | 67 | ||||||
|
|
|
|
|||||
Total net revenues |
$ | 38,524 | $ | 52,128 | ||||
|
|
|
|
2021 |
2020 |
|||||||
(in thousands) |
||||||||
Products transferred at a point in time | $38,524 | $52,128 | ||||||
Products and services transferred over time | — | — | ||||||
Total net revenues |
$ | 38,524 | $ | 52,128 | ||||
January 1, 2022 |
January 2, 2021 |
Change |
||||||||||
(In thousands) |
||||||||||||
TFE: |
||||||||||||
Contract assets: |
||||||||||||
Accounts receivable, unbilled |
$ | 99 | $ | 369 | $ | (270 | ) | |||||
Contract liabilities: |
||||||||||||
Deferred revenue |
$ | 65 | $ | 482 | $ | (417 | ) | |||||
Customer advances |
2,107 | 33 | 2,074 | |||||||||
$ | 2,172 | $ | 515 | $ | 1,657 | |||||||
Photonics (included in discontinued operations): |
||||||||||||
Contract assets: |
||||||||||||
Accounts receivable, unbilled |
$ | — | $ | 5,439 | $ | (5,439 | ) | |||||
Retainage |
— | 126 | (126 | ) | ||||||||
$ | — | $ | 5,565 | $ | (5,565 | ) | ||||||
Contract liabilities: |
||||||||||||
Deferred revenue |
$ | — | $ | 779 | $ | (779 | ) | |||||
2021 |
2020 |
|||||||
Equity-based compensation by type of award: |
||||||||
Stock options | $198 | $504 | ||||||
RSUs |
2,819 | 1,936 | ||||||
Employee stock purchase plan |
986 | 949 | ||||||
|
|
|
|
|||||
Total equity-based compensation * |
$ | 4,003 | $ | 3,389 | ||||
|
|
|
|
2021 |
2020 |
|||||||
Stock Options: |
||||||||
Weighted-average fair value of grants per share |
— | $ | 1.82 | |||||
Expected volatility |
— | 46.06 | % | |||||
Risk free interest rate | — | 0.44% | ||||||
Expected term of options (in years) |
— | 4.39 | ||||||
Dividend yield |
— | None |
Shares |
Weighted Average Exercise Price |
Weighted Average Remaining Contractual Term (years) |
Aggregate Intrinsic Value |
|||||||||||||
Options outstanding at January 2, 2021 |
1,814,467 | $ | 6.66 | 3.08 | $ | 2,520,722 | ||||||||||
Options cancelled and forfeited |
(280,261 | ) | $ | 7.44 | ||||||||||||
Options exercised |
(76,619 | ) | $ | 5.74 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Options outstanding at January 1, 2022 |
1,457,587 | $ | 6.55 | 2.31 | $ | 7,622 | ||||||||||
|
|
|
|
|
|
|
|
|||||||||
Options exercisable at January 1, 2022 |
1,267,664 | $ | 6.74 | 2.08 | $ | 3,513 |
Shares |
Weighted Average Grant Date Fair Value |
Weighted Average Remaining Contractual Term (years) |
Aggregate Intrinsic Value |
|||||||||||||
Non-vested RSUs at January 2, 2021 |
901,634 | $ | 5.30 | 1.50 | $ | 6,500,781 | ||||||||||
Granted |
606,705 | $ | 6.03 | |||||||||||||
Vested |
(382,747 | ) | $ | 5.71 | ||||||||||||
Cancelled |
(92,156 | ) | $ | 4.79 | ||||||||||||
|
|
|
|
|
|
|
|
|||||||||
Non-vested RSUs at January 1, 2022 |
1,033,436 | $ | 5.59 | 1.39 | $ | 4,867,484 | ||||||||||
|
|
|
|
|
|
|
|
2021 |
||||
Weighted-average fair value of grants per share |
$ | 7.65 | ||
Expected volatility |
56.26 | % | ||
Risk-free interest rate |
0.15 | % | ||
Dividend yield |
None |
2020 |
||||
Weighted-average fair value of grants per share |
$ | 3.16 | ||
Expected volatility |
46.7 | % | ||
Risk-free interest rate |
0.25 | % | ||
Dividend yield |
None |
2021 |
2020 |
|||||||
Stock Purchase Rights: |
||||||||
Weighted-average fair value of grants per share |
$ | 2.59 | $ | 2.20 | ||||
Expected volatility |
60.88 | % | 51.49 | % | ||||
Risk free interest rate |
0.08 | % | 0.14 | % | ||||
Expected term of purchase rights (in years) |
0.91 | 1.24 | ||||||
Dividend yield |
None | None |
2021 |
2020 |
|||||||